The current stock price of BASI is 16.44 null. In the past month the price increased by 4.51%. In the past year, price increased by 415.36%.
Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.
Bioanalytical Syst
2701 KENT AVENUE
WEST LAFAYETTE IN 47906
CEO: Robert W. Leasure Jr.
Phone: 765-463-4527
Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product development, compliance and quality control programs. The company provides a broad array of value-added services and products focused on chemical analysis, allowing its clients to perform their research and development functions either ``in-house`` or at the company.
The current stock price of BASI is 16.44 null. The price increased by 9.45% in the last trading session.
BASI does not pay a dividend.
BASI has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BASI.
Bioanalytical Syst (BASI) has a market capitalization of 182.99M null. This makes BASI a Micro Cap stock.
ChartMill assigns a technical rating of 9 / 10 to BASI. When comparing the yearly performance of all stocks, BASI is one of the better performing stocks in the market, outperforming 96.63% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to BASI. BASI has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months BASI reported a non-GAAP Earnings per Share(EPS) of -0.32. The EPS decreased by -190.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -5.54% | ||
| ROA | -5.77% | ||
| ROE | N/A | ||
| Debt/Equity | 2.31 |